C9orf72 and amyotrophic lateral sclerosis: As such, exacerbation of individual DPR toxicity and interaction between DPRs may contribute to C9orf72-related FTD/ALS disease progression and provide one explanation for the heterogeneity of symptoms seen in C9orf72 repeat expansion carriers.